Pirtobrutinib
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL (NCT07744724) | Changzhou No.2 People's Hospital | 2026-07-31 |
| Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL (NCT07744737) | Changzhou No.2 People's Hospital | 2026-07-30 |
| Thiotepa in Combination With Pirtobrutinib (a BTK Inhibitor) and Sintilimab (a PD-1 Inhibitor) for Frail or Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma (NCT07416890) | Zhejiang Cancer Hospital | 2026-02-10 |
Track Pirtobrutinib automatically
Every clearance here is in the API, with alerts when new ones post.